← Browse by Condition
Medical Condition
cardiac surgery associated acute kidney injury
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for cardiac surgery associated acute kidney injury sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
NCT06972082
Recruiting
Prevention and Treatment of AKI VEXUS Guided Post Cardiac Surgery
Enrollment
304 pts
Location
Greece
Sponsor
Onassis Cardiac Surgery Centre
NCT06632613 Phase 2
Recruiting
Efficacy and Safety of ENN0403 in Patients At High Risk for Acute Kidney Injury Following Elective Cardiac Surgery
Enrollment
200 pts
Location
China
Sponsor
EnnovaBio
NCT07418242
Recruiting
Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients
Enrollment
1,491 pts
Location
China
Sponsor
Guowei Tu
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology